HMOX1 and early-onset autosomal dominant Alzheimer disease: Experimental models of various neurological diseases such as chronic ischemic (Khan, [47]), stroke [48], and Alzheimer's disease [49] have shown that inflammation and OS induce downregulation of the Nrf2/HO‐1 signaling pathway.